September's reviewers of the month

Abstract

Like most journals, BJUI relies on the hard work and dedication of its peer reviewers and we are grateful to them all. Each month the Editorial Team nominates peer reviewers whose reviews have stood out for their quality and timeliness and those selected as the best are highlighted on this page in recognition of their exceptional work.

Bernardino Miñana López, Md PhD, is Head of the Department of Urology and Director of the Prostate Centre at the Clínica Universidad de Navarra, in Madrid and Pamplona, Spain.

He is mainly dedicated to prostatic diseases, being an expert in robotic prostatic surgery, holmium laser and focal therapy with irreversible electroporation. He has been a pioneer in Spain in performing MRI-US fusion biopsy, focal therapy and Holmium laser.

In 2008 he was elected coordinator of the Spanish Uro-oncology Group of the Spanish Association of Urology (AEU). Subsequently, in 2012 he was elected Vocal of Scientific Affairs of the AEU until 2016. During this period he directed three national epidemiological studies on prostate, bladder and kidney cancer.

Professor Wah has been appointed at the Leeds Teaching Hospitals NHS Trust (LTHT) as Consultant in Diagnostic and Interventional Radiology since 2003 with sub-speciality interest in Interventional Oncology. She is passionate about practising evidence-based medicine and committed to the highest standards of research methodology. Since 2004, she has established, developed and leads an internationally recognised, clinical and research programme in Interventional Oncology (IO). In 2015, she led the formation of Interventional Oncology United Kingdom (IOUK) within British Society of Interventional Radiology (BSIR) to address this gap and was the founding chair for IOUK(BSIR) from 2015–2018.

Her research IO career highlights to date are- Chief Investigator to translate image-guided histotripsy in liver cancer for #Hope4Liver-trial (2021–2023) and featured in NHS-Executive, Daily Mail, and BBC-Click. This innovative cancer treatment is using focused ultrasound technology and the procedure is ‘scalpel-less’, without radiation and offers faster convalescence time for patients. In March 2023, she was appointed CI for the image-guided histotripsy in renal cancer-CAIN trial and performed the ‘Global-First’ case, which featured on ITV News. From April 2024, she is also the co-theme lead for Minimally Invasive Therapies and Extended Realities at the NIHR Leeds HealthTech Centre (2024–2029)